Cargando…

Paraoxonase-1 and Other HDL Accessory Proteins in Neurological Diseases

Detalles Bibliográficos
Autores principales:	Marsillach, Judit, Cervellati, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000390/ https://www.ncbi.nlm.nih.gov/pubmed/33804040 http://dx.doi.org/10.3390/antiox10030454

Ejemplares similares

HDL Proteome and Alzheimer’s Disease: Evidence of a Link
por: Marsillach, Judit, et al.
Publicado: (2020)

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review
por: Zimetti, Francesca, et al.
Publicado: (2021)

Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer’s Disease
por: Salazar, Jose Gregorio, et al.
Publicado: (2021)

Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease
por: Marsillach, Judit, et al.
Publicado: (2009)

Examining the role of paraoxonase 2 in the dopaminergic system of the mouse brain
por: Garrick, Jacqueline M., et al.
Publicado: (2022)

Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia
por: Zuliani, Giovanni, et al.
Publicado: (2023)

Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL
por: Schilcher, Irene, et al.
Publicado: (2021)

Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity
por: Aggarwal, Geetika, et al.
Publicado: (2021)

HDL-Associated Paraoxonase 1 as a Bridge between Postmenopausal Osteoporosis and Cardiovascular Disease
por: Eren, Esin, et al.
Publicado: (2014)

Paraoxonases at the Heart of Neurological Disorders
por: Khalaf, Fatimah K., et al.
Publicado: (2023)

Methodological constraints in interpreting serum paraoxonase-1 activity measurements: an example from a study in HIV-infected patients
por: Parra, Sandra, et al.
Publicado: (2010)

Introduction to Paraoxonases
por: Aviram, Michael
Publicado: (2012)

Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
por: Marsillach, Judit, et al.
Publicado: (2010)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
por: Romani, Arianna, et al.
Publicado: (2020)

Paraoxonase 1, HDL Subclasses and Post Surgery Acute Inflammation: A Pilot Study
por: Bains, Yasmin, et al.
Publicado: (2019)

Paraoxonase-1 Is Not Associated with Coronary Artery Calcification in Type 2 Diabetes: Results from the PREDICT Study
por: Mackness, Bharti, et al.
Publicado: (2012)

Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1
por: Trentini, Alessandro, et al.
Publicado: (2019)

Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport
por: Ikhlef, Souade, et al.
Publicado: (2017)

Paraoxonase-1 Inhibits Oxidized Low-Density Lipoprotein-Induced Metabolic Alterations and Apoptosis in Endothelial Cells: A Nondirected Metabolomic Study
por: García-Heredia, Anabel, et al.
Publicado: (2013)

Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes
por: Rosta, Valentina, et al.
Publicado: (2020)

HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women
por: Gaillard, Trudy, et al.
Publicado: (2011)

The Effects of Anthocyanins and Their Microbial Metabolites on the Expression and Enzyme Activities of Paraoxonase 1, an Important Marker of HDL Function
por: Aboufarrag, Hassan T., et al.
Publicado: (2019)

HDL Subclasses and the Distribution of Paraoxonase-1 Activity in Patients with ST-Segment Elevation Acute Myocardial Infarction
por: Djekic, Saska, et al.
Publicado: (2023)

Arylesterase activity of paraoxonase 1 (PON1) on HDL(3) and HDL(2): Relationship with Q192R, C-108T, and L55M polymorphisms
por: Valencia C, Sandra Y., et al.
Publicado: (2021)

Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides
por: Sergi, Domenico, et al.
Publicado: (2023)

BACE1: from biomarker to Alzheimer’s disease therapeutical target
por: Cervellati, Carlo, et al.
Publicado: (2021)

Evaluation of Dysfunctional HDL by Myeloperoxidase/Paraoxonase Ratio in Unexplained Infertility Patients Undergoing IVF/ICSI
por: Erdoğan, Kadriye, et al.
Publicado: (2023)

Frontier on Alzheimer’s Disease
por: Cervellati, Carlo, et al.
Publicado: (2023)

Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome
por: Ferretti, Gianna, et al.
Publicado: (2012)

Accessory signals in protein translocation
por: Hansen, Katja G., et al.
Publicado: (2018)

Crosstalk Between Adipokines and Paraoxonase 1: A New Potential Axis Linking Oxidative Stress and Inflammation
por: Tisato, Veronica, et al.
Publicado: (2019)

Paraoxonase-1 and other factors related to oxidative stress in psoriasis
por: Oszukowska, Magdalena, et al.
Publicado: (2020)

The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation
por: Ebtehaj, Sanam, et al.
Publicado: (2017)

BACE1 role in Alzheimer's disease and other dementias: from the theory to the practice
por: Cervellati, Carlo, et al.
Publicado: (2021)

Paraoxonase1, its Q192R polymorphism and HDL-cholesterol in relation to intensive cardiac care unit stay in ischemic heart disease
por: Hampe, Mahesh Harishchandra, et al.
Publicado: (2014)

Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
por: Passaro, Angelina, et al.
Publicado: (2018)

Early elevation of BACE1 in dementia
por: Cervellati, Carlo, et al.
Publicado: (2021)

Reduction of Paraoxonase Expression Followed by Inactivation across Independent Semiaquatic Mammals Suggests Stepwise Path to Pseudogenization
por: Graham, Allie M, et al.
Publicado: (2023)

Paraoxonase 1 and atherosclerosis
por: Durrington, Paul N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fsmvgm3sstssjblqmksjjcmou0